openPR Logo
Press release

Comprehensive Methenamine Hippurate Tablets Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

02-28-2025 01:19 PM CET | Health & Medicine

Press release from: The Business Research Company

Methenamine Hippurate Tablets Market

Methenamine Hippurate Tablets Market

What market dynamics are playing a key role in accelerating the growth of the methenamine hippurate tablets market?
The upsurge in the aged population is anticipated to spur the expansion of the methenamine hippurate tablets market in the future. The term geriatric population encompasses individuals who are 60 years old and above. Geriatric individuals are more susceptible to urinary tract infections due to various reasons such as reduced urine flow, an enlarged prostate, or kidney stones. Therefore, methenamine hippurate tablets are essential for treating these ailments. For example, the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for global public health, has stated that one out of every six people worldwide will be 60 or more by 2030. In 2022, the population of individuals above 60 was 1.4 billion. The global population of individuals who are 60 or more will double by 2050 to 2.1 billion, and the population of individuals over 80 is predicted to triple, reaching 426 million. Therefore, the growth in the senior population is a key driver for the expansion of the methenamine hippurate tablets market.

Get Your Methenamine Hippurate Tablets Market Report Here:
https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

How will the growth rate of the methenamine hippurate tablets market shape industry trends by 2034?
The market size for methenamine hippurate tablets has seen a significant increase in past years. The industry is expected to expand from $9.52 billion in 2024 to $10.21 billion in 2025 with a compound annual growth rate (CAGR) of 7.2%. The former growth can be linked to conventional UTI treatments, worries over antibiotic resistance, clinical verification, doctor prescribing habits, and patients favoring non-antibiotic remedies.

In the upcoming years, the methenamine hippurate tablets market is projected to witness robust growth, expanding to a valuation of $13.78 billion by 2029 with a compound annual growth rate (CAGR) of 7.8%. The growth in this horizon is driven by factors such as increasing UTI incidence, growing concerns over antibiotic resistance, advancements in UTI management, the push for preventive treatment in healthcare, as well as clinical trials and research activities. During the forecast period, key trends such as higher incidence of UTI, increased antibiotic resistance, a move towards non-antibiotic treatment methods, an emphasis on preventive healthcare, and ongoing research and development will prevail.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

What trends are poised to drive the future success of the methenamine hippurate tablets market?
The dominant trend emerging in the methenamine hippurate tablets market is product innovation. Key players in the industry are concentrating on creating groundbreaking products to solidify their market stand. For instance, in May 2023, EQL Pharma, a European pharmaceutical entity specializing in cost-effective generic medications and niche generics for hospitals and pharmacies, revealed its plan to out-license Memprex (methenamine hippurate) to Laboratoires Majorelle for distribution in France. This move enhances Memprex's reach while offering a non-antibiotic alternative for UTI prevention. Laboratoires Majorelle, a company well-recognized for women's health in France, is set to market and distribute Memprex, marking it as a non-antibiotic solution for UTI prevention.

Which primary segments of the methenamine hippurate tablets market are driving growth and industry transformations?
The methenamine hippurate tablets market covered in this report is segmented -

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs
4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:
1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options
2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9412

Which geographical regions are pioneering growth in the methenamine hippurate tablets market?
North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the methenamine hippurate tablets market landscape?
Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

What Is Covered In The Methenamine Hippurate Tablets Global Market Report?

• Market Size Forecast: Examine the methenamine hippurate tablets market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the methenamine hippurate tablets market for a structured understanding.
• Key Players Overview: Analyze major players in the methenamine hippurate tablets market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the methenamine hippurate tablets market.
• Segment Contributions: Evaluate how different segments drive overall growth in the methenamine hippurate tablets market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the methenamine hippurate tablets market.
• Industry Challenges: Identify potential risks and obstacles affecting the methenamine hippurate tablets market.
• Competitive Landscape: Review strategic developments in the methenamine hippurate tablets market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Comprehensive Methenamine Hippurate Tablets Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here

News-ID: 3892241 • Views:

More Releases from The Business Research Company

Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reaching $2.73 Billion by 2029
Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reach …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Semantic Knowledge Graphing Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, there has been significant growth in the market size of semantic knowledge graphing. It is anticipated that the market will expand from $1.49 billion in 2024 to $1.7 billion in 2025,
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 Billion Milestone
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Security Analytics Market Through 2025? The market size for security analytics has rapidly expanded in the recent past. From $17 billion in 2024, it is projected to swell up to $19.74 billion in 2025, representing a compound annual growth rate (CAGR) of
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Technology: A Key Catalyst Accelerating Global Robotic Process Automation (RPA) In Information Technology Market Growth in 2025
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Tec …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Robotic Process Automation (RPA) In Information Technology Industry Market Size Be by 2025? The market size of Robotic Process Automation (RPA) in Information Technology has seen an explosive growth recently. The market is projected to expand from $1.42 billion in 2024 to $1.78 billion in 2025,
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Remote Firmware Market Size By 2025? The market size of remote firmware has experienced substantial growth in the past few years. It is projected to increase from $7.35 billion in 2024 to $8.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the